![Eyal S. Ron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eyal S. Ron
Chief Tech/Sci/R&D Officer at Polyrizon Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Schwartz | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 15 years |
Tomer Izraeli | M | 46 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 19 years |
Mark W. Grinstaff | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 15 years |
Karen English | F | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 20 years |
Raul Srugo | M | 60 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
Liron Carmel | M | 39 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 4 years |
Oz Adler | M | 36 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
Yonah Kalfa | M | 42 |
PharMedica Ltd.
| - |
Peter Lui | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
Liat Sidi | F | 50 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | - |
Nir Ben Yosef | M | 48 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
Bill Keogh | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | 3 years |
Roy Borochov | M | 49 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
Tidhar Turgeman | M | 44 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 4 years |
Daphna Avital | F | 57 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
Yehonatan Zalman Vinokur | M | 46 |
Polyrizon Ltd.
![]() Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Alain J. Hanover | M | 75 |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
Jesse Wolinsky | M | - |
AcuityBio Corp.
![]() AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | - |
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 11 | 61.11% |
United States | 7 | 38.89% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eyal S. Ron
- Personal Network